Pacira BioSciences (PCRX) EBITDA Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly EBITDA Margin of 3.89% for Q1 2026, up 271.0% year-over-year from 1.05% in Q1 2025, and up 227.38% quarter-over-quarter from 1.19% in Q4 2025.
Pacira BioSciences (PCRX) EBITDA Margin (2010 - 2026) Analysis & Trends
Pacira BioSciences' EBITDA Margin history runs 17 years deep, the most recent figure standing at 3.89% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 271.0% year-over-year to 3.89%; the TTM figure through Mar 2026 stood at 3.28% (up 1532.0% YoY), while the FY2025 annual figure was 2.64%, up 1311.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 3.89%, up from 1.19% in the prior quarter.
- The five-year high for EBITDA Margin was 23.53% in Q2 2023, with the low at 82.77% in Q3 2024.
- The 5-year median for EBITDA Margin is 7.91% (2024), against an average of 3.74%.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin slumped 9358 bps in 2024, then jumped 8631 bps in 2025.
- Pacira BioSciences' EBITDA Margin stood at 2.01% in 2022, then jumped by 810 bps to 18.3% in 2023, then decreased by 28 bps to 13.19% in 2024, then tumbled by 91 bps to 1.19% in 2025, then surged by 227 bps to 3.89% in 2026.
- Business Quant data shows PCRX's EBITDA Margin at 3.89% in Q1 2026, 1.19% in Q4 2025, and 3.54% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 2.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22% |
| Mar 31, 2026 | 3.89% |
| Dec 31, 2025 | 1.19% |
| Sep 30, 2025 | 3.54% |
| Jun 30, 2025 | 4.69% |
| Mar 31, 2025 | 1.18% |
| Dec 31, 2024 | 13.19% |
| Sep 30, 2024 | -82.77% |
| Jun 30, 2024 | 15.86% |
| Mar 31, 2024 | 7.91% |
| Dec 31, 2023 | 18.30% |
| Sep 30, 2023 | 10.81% |
| Jun 30, 2023 | 23.53% |
| Mar 31, 2023 | -1.93% |
| Dec 31, 2022 | 2.01% |
| Sep 30, 2022 | 12.71% |
| Jun 30, 2022 | 18.44% |
| Mar 31, 2022 | 11.01% |
| Dec 31, 2021 | 2.65% |
| Sep 30, 2021 | 24.61% |